Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 575-580 , December 2009

Radiosensitivity of squamous cell carcinoma metastases to the neck assessed by immunocytochemical profiling of fine-needle aspiration biopsy cell specimens: A pilot study

  • Margareta Strojan Fležar

      Affiliations

    • Institute of Pathology, University of Ljubljana, Ljubljana, Slovenia
    • ,
  • Irena Srebotnik Kirbiš

      Affiliations

    • Institute of Pathology, University of Ljubljana, Ljubljana, Slovenia
    • ,
  • Katarina Šurlan Popović

      Affiliations

    • Institute of Radiology, University Medical Centre Ljubljana, Ljubljana, Slovenia
    • ,
  • Primož Strojan

      Affiliations

    • Department of Radiation Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
    • Corresponding Author InformationCorresponding author. Address: Department of Radiation Oncology, Institute of Oncology, Zaloška 2, SI-1000 Ljubljana, Slovenia.

Received 1 June 2009 ,Revised 30 August 2009 ,Accepted 2 September 2009.

References 

  1. Bataini JP, Bernier J, Asselain B, et al. Primary radiotherapy of squamous cell carcinoma of the oropharynx and pharyngolarynx: tentative multivariate modelling system to predict the radiocurability of neck nodes. Int J Radiat Oncol Biol Phys. 1988;14:635–642
  2. Mack MG, Rieger J, Baghi M, Bisdas S, Vogl TJ. Cervical lymph nodes. Eur J Radiol. 2008;66:493–500
  3. Vergeer MR, Doornaert P, Leemans CR, Buter J, Slotman BJ, Langendijk JA. Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation. Radiother Oncol. 2006;79:39–44
  4. Rischin D, Hicks RJ, Fisher R, et al. Prognostic significance of [18F]-misonidasole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group study 98.02. J Clin Oncol. 2006;24:2098–2104
  5. Corry J, Smith JG, Peters LJ. The concept of a planned neck dissection is obsolete. Cancer J. 2001;7:472–474
  6. Giardini R, Martelli G, Rilke F, Pilotta S. Diagnostic problems of second primary malignancies detected by fine-needle aspiration cytology. Cancer. 1993;72:2716–2722
  7. Raybaud-Diogène H, Fortin A, Morency R, Roy J, Monteil RA, Têtu B. Markers of radioresistance in squamous cell carcinoma of the head and neck: a clinicopathologic and immunohistochemical study. J Clin Oncol. 1997;15:1030–1038
  8. Couture C, Raybaud-Diogène H, Têtu B, et al. P53 and Ki-67 as markers of radioresistance in head and neck carcinoma. Cancer. 2001;94:713–722
  9. Buffa FM, Bentzen SM, Daley FM, et al. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy. Clin Cancer Res. 2004;10:3745–3754
  10. Trent S, Yang C, Li C, Lynch M, Schmidt EV. Heat shock protein B8, a cyclin-dependent kinase-independent cyclin D1 target gene, contributes to its effects on radiation sensitivity. Cancer Res. 2007;67:10774–10781
  11. Vigneswaran N, Wu J, Nagaraj N, Adler-Storthz K, Zacharias W. Differential susceptibility of metastatic and primary oral cancer cells to TRIAL-induced apoptosis. Int J Oncol. 2005;26:103–112
  12. Strojan P, Karner K, Šmid L, et al. Concomitant chemoradiotherapy with mitomycin C and cisplatin in advanced unresectable carcinoma of the head and neck: phase I–II clinical study. Int J Radiat Oncol Biol Phys. 2008;72:365–372
  13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc. 1958;53:457–481
  14. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer. 1977;35:1–39
  15. Ataman ÖU, Bentzen SM, Wilson GD, et al. Molecular biomarkers and site of first recurrence after radiotherapy for head and neck cancer. Eur J Cancer. 2004;40:2734–2741
  16. Calgaro N, Marioni G, Blandamura S, et al. P27 and MIB-1 expression is related to malignancy recurrence in laryngeal carcinoma treated with partial laryngectomy: preliminary results. J Otolaryngol. 2007;36:98–105
  17. Roepman P, Wessels LFA, Kettelarij N, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinoma. Nat Genet. 2005;37:182–186
  18. Watanabe H, Mogushi K, Miura M, et al. Prediction of lymphatic metastasis based on gene expression profile analysis after brachytherapy for early-stage oral tongue carcinoma. Radiother Oncol. 2008;87:237–242
  19. Benzen SM, Johansen LV, Overgaard J, Thames HD. Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys. 1991;20:1197–1206
  20. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer. 2009;9:239–252
  21. Cabanillas R, Rodrigo JP, Astudillo A, Domínguez F, Suárez C, Chiara MD. P53 expression in squamous cell carcinoma of the supraglottic larynx and its lymph node metastases: new results for an old question. Cancer. 2007;109:1791–1798
  22. Strojan P, Oblak I, Gale N, Šmid L, Kos J. Cysteine cathepsins B and L and their inhibitors stefins A and B in carcinoma of the oropharynx: immunohistochemical study. Histopathology. 2008;53:612–614
  23. Caraway NP. Strategies to diagnose lymphoproliferative disorders by fine-needle aspiration by using ancillary studies. Cancer Cytopathol. 2005;105:432–442
  24. Park K, Han S. Cytologic evaluation p53, cyclin D1, and cathepsin D and their correlation with histologic sections in primary breast carcinoma. J Korean Breast Cancer Soc. 2002;5:113–117
  25. Park K, Han S, Kim H-Y, Ko I. Cytologic evaluation of cyclin D1 expression in primary breast carcinoma. Cancer Cytopathol. 2001;93:211–215
  26. Binks S, Clelland CA, Ronan J, Bell J. P53 gene product expression in resected non-small cell carcinoma of the lung, with studies of concurrent cytological preparations and microwave antigen retrieval. J Clin Pathol. 1997;50:320–323
  27. Dowell SP, Wilson POG, Derias NW, Lane DP, Hall PA. Clinical utility of the immunocytochemical detection of 53 protein in cytological specimens. Cancer Res. 1994;54:2914–2918
  28. Sato Y, Itoh F, Hareyama M, et al. Association of cyclin D1 expression with factors correlated with tumor progression in human hepatocellular carcinoma. J Gastroenterol. 1999;34:486–493
  29. Tut VM, Braithwaite KL, Angus B, Neal DE, Lunec J, Mellon JK. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67. Br J Cancer. 2001;82:270–275
  30. Pfeiffer J, Kayser G, Technau-Ihling K, Boedeker CC, Ridder GJ. Ultrasound-guided core-needle biopsy in the diagnosis of head and neck masses: indications, technique, and results. Head Neck. 2007;29:1033–1040
  31. Pfeiffer J, Kayser L, Ridder GJ. Minimal-invasive core needle biopsy of head and neck malignancies: clinical evaluation for radiation oncology. Radiother Oncol. 2009;90:202–207
  32. Layfield LJ. Fine-needle aspiration in the diagnosis of head and neck lesions: a review and discussion of problems in differential diagnosis. Diagn Cytopathol. 2007;35:798–805
  33. Yip HT, Chopra R, Chakrabarti R, et al. Cisplatin-induced growth arrest of head and neck cancer cells correlates with increased expression of p16 and p53. Arch Otolaryngol Head Neck Surg. 2006;132:317–326

PII: S0167-8140(09)00555-6

doi: 10.1016/j.radonc.2009.09.007

Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 575-580 , December 2009

Article Tools

* Image Usage & Resolution